Suppr超能文献

不同种族人群中凝血酶原 G20210A 多态性与冠心病易感性的关联各不相同:来自 15041 例病例和 21507 例对照的证据。

Varied association of prothrombin G20210A polymorphism with coronary artery disease susceptibility in different ethnic groups: evidence from 15,041 cases and 21,507 controls.

机构信息

Department of Cardiology, Huashan Hospital, Fudan University, 12 Middle Urumqi Road, Shanghai, 200040, China.

出版信息

Mol Biol Rep. 2011 Apr;38(4):2371-6. doi: 10.1007/s11033-010-0370-1. Epub 2010 Nov 16.

Abstract

Published data on the association between prothrombin G20210A polymorphism and coronary artery disease (CAD) risk are inconclusive. To derive a more precise estimation of the relationship, a meta-analysis was performed. A total of 42 case-control studies including 15,041 cases and 21,507 controls were included in this meta-analysis. Overall, significantly elevated CAD risk was associated with prothrombin G20210A polymorphism (OR, 1.22; 95% CI 1.07-1.40; P=0.003) when 39 eligible studies were pooled into the meta-analysis. In the subgroup analysis, borderline statistically increased risk was found for myocardial infarction in 22 case-control studies (OR, 1.27; 95% CI 1.00-1.61; P=0.05). When stratified by ethnicity, significantly elevated risk was found in Europeans (OR, 1.19; 95% CI, 1.02-1.38; P=0.02). However, no statistical differences were found among Americans and Asians. In summary, this meta-analysis indicated that prothrombin G20210A allele is a low-penetrant risk factor for developing CAD in Europeans.

摘要

已发表的关于凝血酶原 G20210A 多态性与冠心病(CAD)风险之间关联的数据尚无定论。为了更准确地评估这种关系,进行了荟萃分析。这项荟萃分析共纳入了 42 项病例对照研究,包括 15041 例病例和 21507 例对照。总体而言,当将 39 项符合条件的研究纳入荟萃分析时,凝血酶原 G20210A 多态性与 CAD 风险显著升高相关(OR,1.22;95%CI,1.07-1.40;P=0.003)。在亚组分析中,在 22 项病例对照研究中发现心肌梗死的风险略有增加(OR,1.27;95%CI,1.00-1.61;P=0.05)。按种族分层时,在欧洲人群中发现风险显著升高(OR,1.19;95%CI,1.02-1.38;P=0.02)。然而,在美洲人和亚洲人中未发现统计学差异。总之,这项荟萃分析表明,凝血酶原 G20210A 等位基因是欧洲人发生 CAD 的低外显度风险因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验